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a b s t r a c t
Standard annuities are offered at one price to all individuals of the same age and gender. Individual
mortality heterogeneity exposes insurers to adverse selection since only relatively healthy lives are
expected to purchase annuities. As a result standard annuities are priced assuming above-average
longevity, making them expensive for many individuals. In contrast underwritten annuity prices reflect
individual risk factors based on underwriting information, as well as age and gender. While underwriting
reduces heterogeneity, mortality risk still varies within each risk class due to unobservable individual
risk factors, referred to as frailty. This paper quantifies the impact of heterogeneity due to underwriting
factors and frailty on annuity values. Heterogeneity is quantified by fitting Generalized Linear Mixed
Models to longitudinal data for a large sample of US males. The results show that heterogeneity remains
after underwriting and that frailty significantly impacts the fair value of both standard and underwritten
annuities. We develop a method to adjust annuity prices to allow for frailty.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.l1. Introduction
Mortality risk varies across individuals due to many factors
including age, sex, education and marital status (Brown and
McDaid, 2003). This heterogeneity poses interesting and important
problems for pricing annuities. The main problem is well known.
Standard annuities are offered at one price to all individuals of
the same age and gender, with no underwriting; if insurers offer
the same price to both low-risk and high-risk individuals, then in
a competitive insurance market either the insurer makes a loss
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Open access under CC BY-NC-ND (if the price is too low to cover payments to high-risk buyers) or
low-risk lives will not buy insurance (if the price is too high by
their assessment) (Rothschild and Stiglitz, 1976). Consistent with
the Rothschild and Stiglitz (1976) theory, low-risk (below-average
longevity) individuals buy fewer annuities than high-risk (above-
average longevity) individuals when a single price is offered.
Thus purchasers of standard annuities have lower mortality than
the general population (Mitchell and McCarthy, 2002). Insurers,
therefore, price annuities with a mortality table that assumes
above-average longevity and the resulting high prices limit the
viability of private annuity markets (Su and Sherris, 2012). To
address this issue, researchers andpractitioners have extended risk
classification of annuitants (Kwon and Jones, 2006) and there has
been significant growth in the market for underwritten annuities
(which are sold at a range of prices to individuals of the same
age and gender depending on underwriting information), in order
to offer lower prices to individuals with below-average expected
longevity (Steinorth, 2012).
icense.
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smoking status, that explainmortality heterogeneity. In addition to
observable factors, heterogeneity may be caused by unobservable
individual-specific factors, referred to as frailty. A large body of
research shows that frailty has a significant impact on estimates
of life expectancy (Manton et al., 1986; Congdon, 1994; Su and
Sherris, 2012). To price underwritten annuities, therefore, it is
important to allow for both observable and unobservable factors.
Underwritten annuities are a relatively new product, so at
present there is no established methodology for pricing annuities
based on underwriting information. The Cox (1972) proportional
hazards model (the PHmodel) is widely used in medical studies to
estimate the relationship between individual characteristics and
survival times. It is suitable for most medical studies because it
adjusts for censoring in survival data and because the model as-
sumptions (namely, that the ratio of the hazard functions of dif-
ferent individuals is constant with respect to time) are reasonable
(Therneau and Grambsch, 2000). It is, however, difficult to incor-
porate time-varying covariates within the PH model (Fisher and
Lin, 1999). This means that the PH model is not a good choice for
modelling survival rates conditional on underwriting information,
because underwriting factors (such asmedical history)may change
over time. Furthermore the incorporation of unobservable factors,
such as frailty, into PH models poses considerable theoretical dif-
ficulties in the development of estimation and inference proce-
dures (Therneau and Grambsch, 2000).
On the other hand, frailty models include unobservable fac-
tors but do not typically include observable factors. Frailty models
allow for heterogeneity via an individual-level unobservable risk
factor. Vaupel et al. (1979) introduce the concept of frailty as an un-
observable risk factor representing an individual’s susceptibility to
death that is fixed throughout his or her lifetime. Traditional frailty
models jointly estimate the parameters for the standard force of
mortality distribution and the frailty distribution from population
data (Su and Sherris, 2012). The way in which frailty is modelled
has a significant impact on estimates of life expectancy. Manton
et al. (1986) adopt Gamma and inverse Gaussian distributions for
frailty and Gompertz, Makeham, Weibull and extended Weibull
distributions for standard force of mortality. They find that esti-
mates of life expectancy are more sensitive to the distribution of
the standard force of mortality than to the distribution of frailty.
The change in life expectancy after frailty is introduced depends
on the analytic form of the survivor function, the way that unob-
served frailty is modelled, the amount of heterogeneity present
and the extent and direction of the change in forecast mortality
rates (Congdon, 1994). In general, life expectancy increases when
a gamma-distributed frailty is introduced (Congdon, 1994). So ig-
noring frailty may lead to underestimation of life expectancy and,
therefore, to underpricing of annuities.
Markov ageing models (MAMs) and generalized linear mixed
models (GLMMs) can also be used tomodel frailty. Like frailtymod-
els, however, MAMs cannot include individual-level observable
factors because they are fitted to population-level data. MAMs are
continuous-time multi-state models with states defined by phys-
iological age (which is a measure of the degree of ageing, or the
level of functionality, of the human body) and death. The probabil-
ity distribution of physiological age at calendar age t may be used
to describe the heterogeneity in health status among the cohort of
individuals at age t (Lin and Liu, 2007). Su and Sherris (2012) show
that frailtymodels imply a reduction in heterogeneity at older ages,
while MAMs imply higher heterogeneity at older ages. These dif-
ferences influence standard annuity prices, with MAMs implying
higher annuity prices than frailty models (Su and Sherris, 2012).
GLMMs are fitted to individual-level data and can jointly model
the effect of observable individual-level characteristics and frailty
onmortality risk. GLMMs extend generalized linearmodels (GLMs)to incorporate random effects characterizing heterogeneity among
subjects. Antonio and Beirlant (2007) show the importance of
GLMMs as a tool in non-life actuarial applications. GLMMshave not
previously been applied to life insurance problems, however they
have been used for survival modelling in other contexts. For exam-
ple,McGilchrist and Aisbett (1991) and Yau andMcGilchrist (1998)
apply a method of estimation of GLMMs to estimate parameters
in a PH model including frailty. The work by McGilchrist, how-
ever, focuses on estimation methods, model fitting and inference
on the fixed effects regression coefficients. Second, McGilchrist ap-
plies GLMMs to repeated events studies within a medical setting
(e.g. number of kidney infections following a particular treatment)
rather than to mortality risk studies.
Very fewmortality studies allow for observable individual-level
characteristics alongside frailty. It is not clear from existing re-
search, therefore, whether heterogeneity is significant after allow-
ing for commonly used underwriting factors, or how frailty affects
the value of annuities after allowing for underwriting factors. These
questions are central to fairly pricing and adequately reserving for
underwritten annuities. The original contribution of this paper is to
quantify the heterogeneity inmortality risk due to individual-level
observable characteristics and frailty and its impact on annuity val-
ues.
First, the heterogeneity implied by underwriting factors and
frailty is quantified by fitting GLMMs. Second we assess the finan-
cial implications of frailty for standard and underwritten annuity
prices. The results confirm that while underwriting explains a sig-
nificant degree of heterogeneity, frailty is still significant even after
allowing for a large set of commonunderwriting factors. Frailty has
a significant impact on standard and underwritten annuity prices,
particularly for lives with below-average health.
The remainder of the paper is organized as follows. Section 2
introduces GLMMs for mortality modelling allowing for both un-
derwriting factors and frailty. Section 3 describes the data from the
United States (US) Health and Retirement Study (HRS), a longitudi-
nal study that surveys a representative sample of theUSpopulation
over the age of 50 every two years. Section 4 presents the model
estimation results and the valuation of annuity contracts, with and
without underwriting and/or frailty. Section 5 concludes the paper.
2. GLMMs for mortality data
This section reviews the basic concepts of GLMs and their ex-
tension to GLMMs. Full details on GLMs and GLMMs are presented
in McCullagh and Nelder (1989) and McCulloch and Searle (2001)
respectively.
2.1. Overview of GLMs and GLMMs
2.1.1. Generalized linear models (GLMs)
GLMs extend ordinary linear regression to the class of distribu-
tions from the exponential family so that outcome measures like
counts, binary and skewed data can be modelled within a regres-
sion framework. Let Y1, . . . , Yn be independent random variables,
assumed to have a distribution from the exponential family such
that
f (y) = exp

yθ − ψ(θ)
φ
+ c(y, φ)

whereψ(.)and c(.) are known functions, θ is the natural and φ the
scale parameter. The following relations hold for the mean and the
variance of Yi
µi = E[Yi] = ψ ′(θi)
and
Var[Yi] = φψ ′′(θi) = φV (µi);
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tionship between the mean and the variance of Y .
GLMs provide a way around having to transform the response
so that it is normally distributed. Instead of using a transformed
data vector, GLMs model a transformation of the mean as a linear
function of explanatory variables, i.e. µi = E[Yi|Xi] is modelled as
g(µi) = Xiβ ′, (1)
where Xi is a (ni × p) matrix of covariate values and β ′ is a (p× 1)
vector of parameters.1
Standard GLMs require that Yi is a sample of independent
random variables. This means GLMs are well suited to modelling
outcomes from cross-sectional data, where the response is
measured only once per subject. In many settings, however, this
independence assumption is not fulfilled. In particular, when
the data is measured repeatedly over time per subject, as in
longitudinal data, it is necessary to allow for dependence between
repeated measurements on the same individual. Mixed models,
such as GLMMs, are a widely used extension of GLMs that allows
for dependence between repeated measurements (Antonio and
Beirlant, 2007).
2.1.2. Generalized linear mixed models (GLMMs)
Assume the longitudinal data consists of N subjects, each
observed over multiple time periods. Let ni denote the number
of observations for the ith subject for whom we observe Yi =
[Yi1, . . . , Yini ]′. As above, there is often dependence between the
repeated measurements over time in Yi. GLMMs extend the mean
function in the GLM by adding random effects to allow for this
dependence. In a GLMM the mean function becomes
g(µi) = Xiβ ′ + Zibi, (2)
where Zi (ni × k) is the design matrix for the k random effects
and bi (k × 1) is a vector of random effects specific to individual
i. Correlation between observations on the same subject arises
because they share the same random effects bi.
Given the vector bi with the random effects for subject (or
cluster) i, the repeated measurements Yi1, . . . , Yini are assumed to
be independent with a density from the exponential family
f (yij|bi, β, φ) = exp

yijθij − ψ(θij)
φ
+ c(yij, φ)

and (similar to the case of GLMs) the following (conditional)
relations hold
µij = E[Yij|bi] = ψ ′(θij)
and
Var[Yij|bi] = φψ ′′(θij) = φV (µij).
As before, ψ(.) and c(.) are known functions, θ is the natural and
φ the scale parameter, and V (.) captures the relationship between
the mean and the variance of Y .
The specification of the GLMM is completed by assuming that
the random effects, bi (i = 1, . . . ,N), are mutually independent
and identically distributedwith density function f (bi|α). Hereby α
denotes the unknown parameters in the density. Traditionally, one
works under the assumption of (multivariate) normally distributed
random effects with zero mean and covariance matrix determined
by α.
1 The unknown but fixed regression parameters in β are estimated by solving
the maximum likelihood equations with an iterative numerical technique (such
as Newton–Raphson). Likelihood ratio and Wald tests are used for inference
purposes. If the scale parameter is unknown, it can be estimated either bymaximum
likelihood or by dividing the deviance or Pearson’s chi-square statistic by its degrees
of freedom (Antonio and Beirlant, 2007).2.2. Mortality modelling using GLMMs
We model and project the probability of death for individual
i at time t, qit , throughout. The GLMM framework is chosen as it
is straightforward to include time varying individual-level factors
and frailty, in contrast to other modelling frameworks (such as the
PH model) where it is difficult to include time varying individual-
level factors and frailty (Fisher and Lin, 1999). A common basis
for comparison across all models is established by using the
complementary log–log function to link qit to the linear predictor
(Xiβ ′).
Longitudinal data (i.e. repeatedmeasurements over time) arises
often in life and health insurance analysis (Antonio and Beirlant,
2007). The longitudinal response for individual i (Yi) is a set of
binary indicators of death in each period. Define the discrete time
hazard rate, which is equivalent to the conditional probability
individual i dies in period t given the individual is alive at the start
of the period with characteristics Xit , as:
qit = Pr[Ti = t| Ti ≥ t, Xit ], (3)
where Ti is the discrete random variable giving the uncensored
time of death of individual i and Xit is a vector of covariate
observations (or underwriting factors) for individual i at time
t . Allison (1982) shows that if Yi = [Yi1, . . . , Yini ] are assumed to
be drawn from a PH model, the hazard rate depends on time and
the covariates Xit as follows.2
qit = 1− exp[− exp(Xitβ ′)]. (4)
Therefore if we assume proportional hazards, the discrete time
hazard function is given by the complementary log–log function of
the linear predictor.
The specification of the GLMM is completed by assuming that
the random effects, b = [bi, . . . , bN] (k by N), are mutually in-
dependent and identically distributed (i.i.d.) with density function
f (bi|α), where α is the set of unknown frailty parameters and that
qit = E(Yit |Xit) = 1− exp[− exp(Xitβ ′ + Zibi)]. (5)
As the response data is binary it is assumed that the variance func-
tion is given by Var[Yit |bi] = µi(1− µi).
Vaupel et al. (1979) introduce the concept of frailty as an
unobservable risk factor representing an individual’s susceptibility
to death. The main assumption of Vaupel et al. (1979) is that there
is a unique value of frailty associated with each individual, that is
fixed throughout his or her lifetime. Within a GLMM framework,
the corresponding representation of frailty is via a time-invariant
random individual effect, bi, in the expression
qit = E(Yit |Xit) = 1− exp
− exp(Xitβ ′ + bi) (6)
where the frailty factors b = [b1, . . . , bN] are assumed to be i.i.d.
with bi ∼ N(0, σ 2b ). Using a single random effect to model frailty
means themodel ismore parsimonious, easier to interpret and less
prone to overfitting (Dion, 2011).
2 Alternatively the complementary log–log model can be derived by assuming
proportional hazards and defining a survival model for repeated measures of
interval-censored data. Collett (1994) shows that for repeatedmeasures of interval-
censored data
log[− log(1− qit )] = ηit + γt
where qit is the probability of death in interval t (i.e. qit = 1 − Si(tj)Si(tj−1) ), ηit is
the linear predictor for subject i and may contain time-varying covariates, and
γt , t = 1, . . . , T , are constants associated with the T time intervals.
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Let fit(yit |bi) denote the density function of Yit given bi. The
marginal distribution of Yi is then given by
f (yi) =
 ni
j=1
fij(yij|bi)f (bi)dbi, (7)
and the joint likelihood function for models with frailty and the
unknown parameters β and α is
L(β, α; y) =
N
i=1
f (yi|β, α)
=
N
i=1
 ni
j=1
fij(yij|bi, β, α)f (bi|α)dbi (8)
where the integral is with respect to the vector bi. For linear mixed
models, closed-form expressions exist for the maximum likeli-
hood estimator of themodel parameters. For GLMMs, however, ap-
proximations to the likelihood or numerical integration techniques
are required to maximize the likelihood function with respect to
the unknown parameters. Statistical software (like SAS) contains
in-built functions that estimate GLMMs via maximum likelihood
techniques.
Alternatively, GLMMs can be estimated using Bayesianmethods
such as Markov Chain Monte Carlo (MCMC) simulations. Bayesian
implementation of GLMMs enables the specification of more com-
plicated structures for the linear predictor (for example, multiple,
crossed and/or nested random effects) and for non-normal dis-
tributions to be used for the random effects. A drawback of the
Bayesian approach is that it treats all unknown parameters in the
GLMMas randomvariables forwhich priorsmust be specified. This
means that Bayesian approaches require more assumptions and
are more computationally intensive than maximum likelihood es-
timation (Sargent, 1998). In applications without complex struc-
tures of randomeffects, or non-normal randomeffect distributions,
maximum likelihood techniques require fewer assumptions and
are easier to implement. Therefore as there is only one random ef-
fect in (6) we use maximum likelihood estimation. (See Antonio
and Beirlant (2007) for further details on estimation techniques for
GLMMs.)
2.4. Choice of explanatory variables
In order to test whether frailty has a significant impact on mor-
tality rates and annuity values after underwriting, it is necessary to
define a baseline model which has no underwriting and to estab-
lish the impact of frailty on mortality rates and annuity values in
the baseline model.
Baseline model (no underwriting) The baseline model mimics the
type of rating performed for a policy that is priced solely on age
and gender. The model includes only year and age as covariates,
and is fitted to data for males only (i.e. gender specific mortality
rates).
Survival model with underwriting. Brown and McDaid (2003) iden-
tify 10 potential risk factors influencing mortality including edu-
cation, marital status, income, occupation, race, health behaviour
and religion. First, risk factors should only be used for underwrit-
ing if they are objective and readily measurable. Of the afore-
mentioned factors, health behaviour is difficult to monitor and
measure, however weight (or Body Mass Index (BMI)), smoking
status and past medical history are typically used for underwriting
as these factors can be reliablymeasured. Second, race and religion
cannot be used as underwriting factors in the US (Brown and Mc-
Daid, 2003). Finally, education, occupation and income are highlyTable 1
Summary statistics for the cohort of HRS males.
N 4592 Mean Std. Dev.
Age 61.8 5.4
Education Less than high school 24%
GED, HS or some college 54%
College and above 21%
Marital status Married 79%
Married, spouse away 1%
Partnered 3%
Separated 2%
Divorced 7%
Separated or divorced 1%
Widowed 4%
Never married 3%
BMI Underweight 1%
Normal weight 27%
Overweight 47%
Obese 19%
Morbidly obese 6%
Smoked ever 73%
Smoked now 22%
Health history High blood pressure 45%
Diabetes 15%
Cancer 7%
Lung disease 7%
Heart problems 20%
Stroke 5%
Arthritis 42%
Psychiatric problems 8%
collinear, since current income andwealth are linked to occupation
which is strongly affected by education and health (Fong, 2011).
Therefore income, occupation, race and religion are excluded from
the set of predictors available, leaving education, marital status,
BMI, smoking status and medical history to mimic a realistic un-
derwriting setting.
3. Data
Longitudinal mortality data was obtained from the HRS. The
HRS contains individual-level data collected every two years,
in biennial survey ‘waves’ starting from 1992. Each subject
contributes one set of observations over the measured variables
per wave, provided they have not left the study (due to death
or other exit reason). All models are fitted to data for subjects
born from 1931 to 1941, who entered the study in 1992, since
this cohort represents the retired population with the greatest
potential demand for annuity contracts and also has the longest
time series of data available. As death data may be delayed, the
last year of deaths are not reliable as theremay be incurred but not
reported deaths. Therefore only data up to 2006 was used in order
to ensure that all deaths within the study period were captured.
The final datasetwas an unbalanced panel of 4592males, eachwith
up to 8 biennial observations.
Statistics summarizing the dataset are shown in Table 1.
Readily-measurable mortality risk factors available in HRS data in-
clude race, education, smoking status, marital status, prior health
history, BMI and income. The average age within the panel was
62 years, and the average birth year of the individuals was 1936.
Most individuals within the representative sample of the popula-
tion of US males had some high school or college education, were
married, overweight and had smoked in the past but not over the
sample period (1992–2006). The most prevalent medical condi-
tions among the sample were high blood pressure and arthritis.
4. Results
In order to quantify the impact of frailty before and after un-
derwriting, models fitted based only on gender, age and time are
compared to models fitted allowing for gender, age, time and
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GLM and GLMM (frailty) models of HRS male mortality rates: Baseline and Underwritten. The second column details the results of the GLM
of mortality explained by time (Wave) and age; the third column details the results of the GLMM (which includes frailty) of mortality explained
by time (Wave) and age; the fourth column details the results of the GLM of mortality explained by time (Wave), age and underwriting factors;
the fifth column details the results of the GLMM (which includes frailty) of mortality explained by time (Wave), age and underwriting factors.
βˆ Baseline Underwritten
GLM GLMM (Frailty) GLM GLMM (Frailty)
I(Wave = 1) −8.45 *** −11.88 *** −6.37 *** −8.83 ***
I(Wave = 2) −8.36 *** −11.64 *** −6.29 *** −8.63 ***
I(Wave = 3) −8.52 *** −11.70 *** −6.46 *** −8.69 ***
I(Wave = 4) −8.35 *** −11.44 *** −6.29 *** −8.46 ***
I(Wave = 5) −8.34 *** −11.32 *** −6.27 *** −8.34 ***
I(Wave = 6) −8.57 *** −11.47 *** −6.54 *** −8.55 ***
I(Wave = 7) −8.51 *** −11.33 *** −6.53 *** −8.54 ***
I(Wave = 8) −8.67 *** −11.42 *** −6.76 *** −8.74 ***
Age 0.08 *** 0.12 *** 0.06 *** 0.08 ***
Education:
HS or some college −0.12 . −0.17
College and above −0.38 *** −0.51 ***
Partnered −0.35 *** −0.50 ***
BMI:
Normal weight −1.08 *** −1.29 ***
Overweight −1.51 *** −1.84 ***
Obese −1.72 *** −2.14 ***
Morbidly obese −1.53 *** −1.97 ***
Smoked ever 0.39 *** 0.53 ***
Smoked now 0.39 *** 0.50 ***
Health history:
High blood pressure 0.32 *** 0.42 ***
Diabetes 0.73 *** 0.91 ***
Cancer 0.89 *** 1.41 ***
Lung disease 0.65 *** 0.97 ***
Heart problems 0.51 *** 0.71 ***
Stroke 0.55 *** 0.90 ***
Psychiatric problems 0.42 *** 0.78 ***
Std. Dev. Frailty (σb) 1.83 1.56
AIC 9967 9809 8864 8737
LL −4894 −4342underwriting factors. All models are fitted with and without al-
lowing for unobservable frailty. Finally, we calculate annuity rates
based on the estimates from each set of models, for a whole of life
annuity and a deferred annuity paid from age 65.
4.1. Model diagnostics
To check that the functional form of the predictors in the base-
linemodel was approximately linear, a generalized additivemodel
(GAM) was fitted to the (complementary log–log) transformed
data for HRS males
log[− log(1− Yit)] = c + f1(ait)+ f2(t)
where ait is the age of individual i at time t . The GAM fits a non-
parametric smoothing function to the relationship between the co-
variates and the response. Fig. 1 shows that age and time effects
are well described by a linear function when the response is trans-
formed by the complementary log–log link, so models (4) and (6)
are reasonable.
4.2. Model estimation
The frailty model is a GLMM including a random intercept
for each individual as in (6). The estimated parameters for the
standard model and the underwritten model, (4) and (6), with
and without frailty are shown in Table 2. The coefficient estimates
are reasonable and consistent with the results of previous studies
and indicate that mortality risk is: reducing over time, lower for
people with higher levels of education, higher for people whose
health history includes serious illness, and higher for underweightindividuals relative to normal and overweight individuals.3 The
estimates of σb, the standard deviation of the frailty, show that
frailty remains significant (σb remains greater than zero) even
after controlling for a large number of underwriting factors. This
suggests that it is important to consider adjusting the price of both
standard and underwritten annuities for frailty.
The parameter estimates from the GLM (without frailty) and
the GLMM (with frailty) are different for both the baseline and
underwritten models. This is because GLM parameters capture
the population-averaged effect of covariates on the response,
while GLMM parameters capture the subject-specific effect of
covariates. The population-averaged probability will differ from
the subject-specific profiles more as the variation across subjects
increases (Verbeke and Molenberghs, 2000). If there is very little
variation in subject-specific random effects, then the coefficients
of the GLM will be closer to the GLMM.4 In Table 2 the estimated
coefficients of the baseline GLM are significantly different to
those of the baseline GLMM, which implies that there is a
significant degree of variation across the subject-specific random
effects (frailty variables). The smaller difference between the GLM
and GLMM coefficients when underwriting factors are included
3 Quantitative analysis of existing studies of the relationship between BMI and
mortality risk have found increased mortality at low BMI for white men relative to
that observed at extreme overweight, which does not appear to be due to smoking
or existing disease (Troiano et al., 1996).
4 In general, parameter estimates obtained from a GLMM will be larger in
absolute value than their GLM counterparts (Neuhaus et al., 1991). Similarly, when
covariates are omitted the population averaged effect of covariate X will be closer
to zero than the cluster-specific effect of X , which is the true underlying effect of X
when the omitted covariate is included.
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c + f1(ait )+ f2(t).
shows that the underwriting factors capture a significant degree
of heterogeneity across individuals’ mortality risk. Consistently,
Table 2 shows that the underwriting factors are all statistically
significant.
The results also show that frailty remains significant after al-
lowing for a large number of underwriting factors. In particular,
comparing the baseline and underwritten models shows that al-
lowing for a large number of underwriting factors only reduces the
variance of frailty 27% from 1.832 to 1.562. That is, heterogeneity
inmortality risk due to frailty is still significant after underwriting.
The financial impact of this change in unobservable heterogeneity
on life expectancy and annuity values is discussed in Section 4.3.2.
Finally the AIC of the Underwritten GLMM was lower than any of
the other models.5 So while underwriting factors capture a signifi-
cant degree of variation in mortality risk, frailty creates additional
variation in mortality risk after underwriting. This suggests that it
is important to allow for both frailty and observable risk factors
when pricing annuities.
Fig. 2 shows the fitted mortality rates from the baseline GLMM
(allowing for frailty but not underwriting) for each individual in
the HRS male sample. The dashed line shows the mean predicted
probability of death at each age.
Fig. 2 illustrates the significant heterogeneity in individual-
level hazard rates, captured by the variation of individualmortality
risk about the average mortality risk (dashed line). Different
individuals of the same age and gender have different hazard rates.
A small number of the HRS males have hazard rates far above the
average, while a large number of the HRS males have hazard rates
a small amount less than the average. Variation in the curves of
individualmortality rates by age arises because of both time effects
and frailty. In this model, as the sample period is relatively short
5 The likelihood numbers in the GLM and GLMMs are not comparable
because different methods are used to approximate the likelihood functions
in GLMMs (quasi-likelihood rather than a true likelihood). Many statisticians
warn that likelihood-based methods should not be used for inference with
quasilikelihoods (Bolker et al., 2009).Fig. 2. Fitted mortality rates from the Baseline GLMM (frailty model). The dashed
line shows the mean predicted probability at age.
and all individuals are from the same cohort, frailty accounts for
most of the variation across individuals of the same age.6
4.3. Implications for annuity pricing
In this section we investigate how frailty impacts the actuarial
present value of standard and underwritten annuities. The GLMs
and GLMMs fitted in the previous section are used to calculate
expected values of annuities and the x% frailty value of annuities
for a whole of life annuity and a 20 year deferred annuity paid
from age 65. The x% frailty value is defined as the expected present
value of an annuity sold to individuals with frailty in the bottom
(1 − x) percentile of the frailty distribution (that is, the x% least
frail individuals). For example, say an insurer believed that the lives
buying annuities were the least frail 15% of the general population,
then they would charge the 85% frailty value of annuities.
4.3.1. Method
The HRS survey waves are every two years. Therefore the
predictions from models (4) and (6) are predictions of the
probability of death within the preceding two year interval. For a
life aged x themodel prediction µˆx(t) = 1−exp

− exp(Xit βˆ ′)

=
2qx−2(t). These biennial mortality rates can be decomposed into
annual mortality rates as shown in the Appendix.
We calculate the projected survival rates for a life aged
65 in 2006 (the final year of the data) using the cohort-
based approach explained in Pitacco (2004), i.e. we calculate
q66(2007), q67(2008), . . . , q65+t(2006 + t). In future years, we
assume an annual rate of mortality improvement equal to the
average annual rate of mortality improvement over the period
1992–2006. This means that the time effect in projection year t
is βˆt = βWave=8 + (t − 2006)8n=2 βWave=n−βWave=n−12 /7, i.e. the
improvement up to 2006, βWave=8, plus the number of years since
2006 times the average annual rate ofmortality improvement over
the period 1992–2006 (Waves 1–8).7
6 The coefficient of variation (the standard deviation of b divided by the mean
of b) is the standard measure of the level of heterogeneity in population (Olivieri,
2006). The coefficient of variation of death rates as fitted by the Baseline GLMM
decreases with age, consistent with the theory that the most frail die earliest so
that survivors have lower frailty (Vaupel et al., 1979).
7 The biennialmortality improvement is equal to the difference in the coefficients
on the time dummies for consecutive Waves shown in Table 2, i.e. βWave=n −
βWave=n−1 . To get the average annual rate ofmortality improvement over the period
1992–2006, therefore, we average these differences divided by 2.
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Risk profiles for underwritten annuity purchases.
Low risk Medium risk High risk
Education College or above HS or some college Not completed HS
Partnered Yes Yes No
BMI Normal Overweight Underweight
Smoker Never Before, not currently Before and currently
Medical conditions None High BP High BP and DiabetesAnnuity values are calculated from the projected survival rates
using discount rates of 4%p.a. (the UK government bond rate in
March 2002) and 3%p.a. corresponding annuity values reported
in Cannon and Tonks (2009) and Su and Sherris (2012) respectively.
The annuity values are calculated to demonstrate the financial
impact of including frailty and underwriting factors in mortality
models and do not include any allowance for expenses, profit
loading or frictional costs.
Frailty models do not provide a specific valuation of the
mortality of an individual (Olivieri, 2006). GLMMs, however,
provide an estimate of the expected subject-specific mortality
rate and the distribution of frailty in the population. Estimates
of the mortality of an individual are equal to the sum of the
model predicted expected values and an adjustment for frailty.
The adjustment for frailty is zασb, where zα is the α percentile of
the standard normal distribution and σˆb is the estimated standard
deviation of the frailty variable. The frailty adjustment is calculated
based on the estimated distribution of the frailty in the population,
which is assumed to be normal with mean zero and variance σˆ 2b .
So individuals in the ‘least frail’ α percentile of the population are
assumed to have a negative frailty value of zα σˆb = −z1−ασˆb,8 and
individuals in the ‘most frail’ α percentile of the population are
assumed to have a positive frailty value of z1−α σˆb. The adjusted
expected mortality rates for the least frail α% of the population are
therefore
qˆxt(α) = 1− exp[− exp(Xit βˆ ′ + zασˆb)]. (9)
For example, with no underwriting, the predicted death rates for
individuals in the healthiest 5% of the population are calculated by
adding z0.05σˆb = (−1.645)(1.83) onto the linear predictor Xitβˆ
and evaluating (6).
It is important to note that Eq. (9) contains separate adjustment
for observable underwriting factors (Xit βˆ ′) and for frailty (zα σˆb).
The underwriting adjustment depends on an individual’s observ-
able characteristics, Xit, and allows the insurer to offer different
prices to different individuals (or risk classes) within the popula-
tion. The frailty adjustment, however, is the same for all individuals
and is based on the estimated distribution of the frailty across the
population.9
Profiles were developed for low, medium, and high risk
individuals based on the characteristics of the sample of the US
population over 50 shown in Table 1. For example, low risk males
had high levels of education, were married, had normal BMI and
had never smoked or had any serious medical conditions. The
profiles are summarized in Table 3. Estimates were obtained for
each profile by evaluating (9) using the different covariates values
corresponding to these profiles.
8 As zα = −z1−α for the standard normal distribution.
9 The frailty adjustment is designed to control for frailty, a mean-zero time-
invariant individual-level random effect with a continuous distribution across
the population. If it is not possible to include some risk factors in underwriting,
e.g. gender, frailty adjustments are not the best way to correct the price because
the omitted risk factor is likely to have a non-zero mean effect on mortality rates.
A more accurate way of adjusting the price for omitted risk factors would be to
develop an accurate assessment of the implied heterogeneity due to the omitted
factor and adjust prices accordingly (Olivieri, 2011).Table 4
Expected value of $1 for life for a male aged 65, at 4%.
Baseline Underwritten
Standard Low Medium High
GLM 12.33 18.57 17.29 4.20
Frailty - 50% 12.28 18.66 17.03 3.57
Frailty - 75% 15.95 19.92 19.15 6.75
Frailty - 85% 17.54 20.25 19.78 8.85
Frailty - 95% 19.36 20.54 20.34 12.55
Frailty - 99.5% 20.44 20.68 20.63 17.33
UK Avg. March 2002 11.89 – – –
Table 5
Expected value of 20 year deferred annuity for a male aged 65, at 4%.
Baseline Underwritten
Standard Low Medium High
GLM 1.77 6.04 5.16 0.03
Frailty - 50% 1.27 5.86 4.57 0.00
Frailty - 75% 3.52 6.90 6.26 0.09
Frailty - 85% 4.78 7.19 6.78 0.39
Frailty - 95% 6.36 7.43 7.26 1.70
Frailty - 99.5% 7.33 7.55 7.51 4.80
4.3.2. Results
First, the expected value of $1 per annum for life paid to a male
aged 65 at 200610 was calculated using the projected mortality
rates implied from eachmodel discounted at 4% (in order to obtain
comparable values to those listed in Cannon and Tonks (2009)).
The predicted mortality rates from the GLM yield an annuity
value (12.33) that is just 4% (see Table 4) higher than the average
market price of an annuity for a male aged 65 listed in Cannon
and Tonks (2009) of 11.89 (see Table 6). The 50% frailty value from
the frailty model (12.28) is also comparable to the market price of
annuities. For underwritten annuities, annuities sold to low risk or
medium risk individuals (as per Table 3) hadmuch larger expected
values than annuities sold to high risk individuals, reflecting the
shorter expected lifetime for high risk lives. The 95% frailty value of
an underwritten annuity for high risk lives (12.55)was comparable
to the average market price of standard UK annuities reported
in Cannon and Tonks (2009) (11.89).
The different prices obtained for standard and underwritten
annuities in Tables 4 and 5 illustrate that when underwriting
factors are incorporated into pricing it is possible to offer much
lower prices to impaired (high risk) individuals. The results also
show that the fair value of an annuity promise to low risk
individuals (with long expected lifetimes) is higher than the
standard annuity price based only on age and gender. The results
suggest that underwriting results in fairer annuity prices because
individuals with longer expected lifetimes paymore for an annuity
than individuals with short expected lifetimes.
For both standard and underwritten annuities, the 50% frailty
values are comparable to the (population-averaged) prices ob-
tained from the GLM with no allowance for frailty (e.g. 18.57 vs.
10 Using the standard annuity valuation formula, a65 =∞k=1(1+ i)−kkp65 , where
kp65 =k−1t=0 1− q65+t (2006+ t) and i is the valuation interest rate.
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UK annuity price of $1 for life formen aged x onMarch 2002 fromCannon and Tonks
(2009).
Company 60 65 70 75
AMP NPI 14.88 12.67 10.42 8.26
AXA Sun Life 14.33 12.50 10.52 8.62
B & CE Insurance 13.30 11.44 9.49 7.61
BRS Smoker 12.72 10.95 9.07 7.27
BRS Plus 12.52 10.66 8.73 6.93
BRS Special 12.17 10.21 8.23 6.44
Canada Life 14.10 12.36 10.50 8.65
Friends Provident 13.97 12.24 10.52 8.86
GE LIFE 15.34 13.76 11.96 10.02
GE LIFE (special) 12.71 10.80 8.85 7.00
Legal and General 13.85 12.24 10.56 8.92
MGM (Select) 12.77 11.12 9.40 7.59
Norwich Union 14.64 13.09 11.09 9.29
Pension Annuity FS 11.70 9.97 8.54 6.71
Prudential 13.81 11.96 10.01 8.10
Royal Liver 14.66 12.77 10.74 8.72
Scottish Equitable 14.37 12.50 10.65 8.83
Scottish Widows 13.83 12.05 10.16 8.31
Standard Life 14.49 12.69 10.81 8.93
Average 13.69 11.89 10.01 8.16
Max 15.34 13.76 11.96 10.02
Min 11.70 9.97 8.23 6.44
18.66 for low risk lives). Furthermore the variation in the frailty
values of underwritten annuities for low risk and medium risk
lives was significantly lower than the variation in the frailty val-
ues of standard annuities (18.66–20.68 and 17.03–20.63 versus
12.28–20.44). This is because the underwriting factors explain a
significant amount of variation in mortality rates that is attributed
to frailty in the standard annuity model. The largest degree of
variation in annuity values due to frailty was for high risk lives
(3.57–17.33). This is because any differences in projected survival
rates are more noticeable due to the shorter discounting period.
Therefore it is important to allow for frailty when pricing under-
written annuities for high risk lives because frailty can make a sig-
nificant difference to annuity values.
4.3.3. Comparison to other frailty models
We also compare the annuity prices implied by the GLM and
GLMMs to the corresponding results in Su and Sherris (2012). Su
and Sherris (2012) quantify heterogeneity and its financial
implications for annuity prices using frailty models and a Markov
ageingmodel (originally proposed by Lin and Liu (2007)) calibrated
to Australian population mortality data. They use a valuation
interest rate of 3%. Given the reference populations in this paper
and Su and Sherris (2012) are different we expect different annuity
values; however the comparison is still useful in highlighting the
sensitivity of annuity values to the type of frailty model used.
The results from Su and Sherris (2012) and the results from
the GLM and GLMMs with and without frailty and underwriting
factors are compared for a whole of life annuity and a 20 year
deferred annuity in Tables 7 and 8 respectively. The baseline
GLMM (frailty model with no underwriting) produces reasonableTable 8
Expected value of 20 year deferred annuity for a male aged 65, at 3%.
3% Standard Su Sherris (2012) Underwritten
Markov Frailty Low Medium High
GLM 2.26 8.07 6.87 0.03
Frailty - 80.6% 5.45 5.34 4.32 9.47 8.75 0.26
Frailty - 61.7% 2.79 4.55 2.94 8.57 7.19 0.01
Frailty - 43.1% 1.05 3.63 1.66 7.20 5.22 0.00
Frailty - 23.5% 0.14 2.99 0.47 4.89 2.72 0.00
Frailty - 13.3% 0.01 2.46 0.08 3.09 1.29 0.00
Frailty - 0.41% 0.00 1.50 0.00 0.02 0.00 0.00
annuity values compared to the frailty models fitted to Australian
population data in Su and Sherris (2012), which assume an Inverse
Gaussian distribution for the frailty. The MAMs, however, imply
higher annuity values than those from either the GLM or GLMMs
fitted in this paper or the frailty models in Su and Sherris (2012).
This is because they imply greater heterogeneity at older ages (Su
and Sherris, 2012). In summary, the GLMMs proposed in this
paper produce very similar annuity values to the frailty models
assuming an InverseGaussian distribution in Su and Sherris (2012).
Frailty models, however, cannot incorporate underwriting factors
as they are based on population data. The GLMM methodology
has the advantage of being able to control for both underwriting
information and frailty.
5. Conclusion
We modelled the heterogeneity implied by underwriting fac-
tors and frailty and quantified the financial impact of frailty on
standard and underwritten annuity values. The relative impor-
tance of frailty declines when underwriting factors are included
in the model, however frailty creates significant heterogeneity in
mortality rates even after allowing for a large set of underwriting
factors. It is therefore important to allow for frailty in applications
that call for estimates of individuals’ mortality risk, even after un-
derwriting.
In terms of the financial impact of frailty, two key results hold.
First, underwriting reduces the level of heterogeneity and its im-
pact on the fair value of annuities. Second, significant variation in
the fair value of annuities remains after underwriting due to frailty.
Finally, the impact of frailty on annuity values is greatest for lives
with below-average longevity because of the shorter discounting
period.
These results have important implications for the pricing of an-
nuities and other life-contingent insurance products. The commer-
cial implication of differentiating prices by underwriting is that
insurers can offer annuities at lower prices to impaired lives. This
is justified because pricing is fairerwhen it is based on all available,
reliable predictors of an individual’s expected lifetime. A frailty ad-
justment, on the other hand, implies a price increase for all individ-
uals in order to protect the insurer against anti-selection. The re-
sults show that a frailty adjustment is justified, for both standard
and underwritten annuities, because there is significant hetero-
geneity in mortality risk (even after underwriting) which meansTable 7
Expected value of $1 for life for a male aged 65, at 3%.
3% Standard Su Sherris (2012) Underwritten
Markov Frailty Low Medium High
GLM 13.68 21.71 20.06 4.40
Frailty - 80.6% 19.20 19.44 18.12 23.69 22.87 8.37
Frailty - 61.7% 15.60 18.31 16.36 22.65 21.02 5.06
Frailty - 43.1% 12.24 16.83 14.38 21.03 18.55 3.06
Frailty - 23.5% 8.36 15.63 11.49 18.11 14.87 1.65
Frailty - 13.3% 5.87 14.44 9.18 15.48 12.05 1.16
Frailty - 0.41% 1.07 11.15 2.59 5.25 3.17 0.94
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low for frailty protects the insurer against adverse selection and
reduces the likelihood an insurer will default on its promises.
Incorporating frailty in the pricing of underwritten annuities
means that an insurer can offer lower annuity prices to lives
with below-average life expectancy, whilst also protecting itself
against adverse selection. Neglecting to adjust annuity prices for
frailty may result in under-pricing and under-reserving which
could threaten the sustainable growth of themuch needed annuity
market.
Appendix. Projecting annual survival rates from a GLM fit to
biennial data
The HRS survey waves are every two years. Therefore the
predictions from the models fitted to this data are predictions of
the probability of death within the preceding two year interval;
that is, for a life aged x at time t the model prediction yˆx = 2qx−2.
These biennial mortality rates can be split into annual mortality
rates as follows
2qx−2 = qx−2 + (1− qx−2)qx−1 ≈ qx−2 + qx−1. (10)
Therefore if we know the starting rate of mortality qx−2, then all
subsequent annual mortality rates can be calculated as
qx+n = 2qx+n−1 − qx+n−1. (11)
The starting rate of mortality is q65. We estimate this value using
the estimated biennial probability of death for a 65 year old in the
last year of the survey data used (2006). Assuming that q66 = cq65
and q67 = cq66 then
2q65 ≈ (1+ c)q65 (12)
and
2q66 ≈ c(1+ c)q65 (13)
it follows that
q65 ≈ 2q651+ 2q66
2q65
. (14)
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